Clinical Trials Browser

Phase 2/3 × Inflammatory Breast Neoplasms × Cisplatin × Clear all

NCT02221999 2023-08-29

SHPD002

Phase 2/3 Active not recruiting

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms